Bivalent vaccine

Those in Singapore can now get their doses of bivalent Moderna/Spikevax vaccine from as early as Oct. 14 onwards. This is three days earlier than the previous ...

- JTVC Yishun - JTVC Woodlands - JTVC Sengkang - JTVC Commonwealth Both Ong and co-chair of the Multi-Ministry Taskforce Gan Kim Yong received their doses of the bivalent Moderna/Spikevax vaccine today (Oct. - JTVC Bukit Merah

SINGAPORE - The Ministry of Health on Friday (Oct 7) said Singapore was transitioning to a new strategy for Covid-19 vaccinations, with a focus on being up ...

However, the Expert Committee on Covid-19 Vaccination still recommends they consider taking either the mRNA vaccines from Moderna and Pfizer-BioNTech or the Novavax vaccine as a booster due to the better protection conferred. The Sinovac-CoronaVac vaccine was earlier available as a booster for only those medically ineligible to receive the mRNA and Novavax/Nuvaxovid vaccines. Do I need a second booster? Pfizer's bivalent vaccine is still under evaluation, but is expected to be available in Singapore by the end of the year. The Expert Committee on Covid-19 Vaccination has recommended the use of the bivalent vaccine to replace the existing formulation. What are bivalent vaccines?

This means events with more than 500 participants, and dining in at F&B establishments will no longer be linked to an individual's vaccination status.

He also assured that vaccination for children aged six months to five years with the Moderna/Spikevax vaccine is safe. - After achieving minimum protection, persons aged 50 years and above should receive an additional booster dose between five months to one year from their last dose, to keep up-to-date with their COVID-19 vaccination. This will apply to all adults aged 18 years and above. HSA has also reported a declining rate of SAEs with further shots (i.e., even fewer have adverse reactions after taking boosters compared to taking primary series)." The vaccine from Pfizer BioNTech/Comirnaty, which is a three-dose vaccine for children aged six months to four years, has also been approved and is awaiting delivery by end-2022. Vaccinations for children aged six months to four years will begin on 25 October. Serious adverse events (SAEs) have been reported in about six in 100,000 vaccinations of the original formulation, and all have recovered or are recovering. Individuals are advised to adhere to the following two key recommendations, namely: Under this arrangement, everyone should keep up-to-date with the latest vaccination recommendations. - Individuals should ensure that they achieve minimum protection. This may include implementing an appropriate level of VDS, as was necessary during the height of the pandemic. However, even as VDS are lifted, non-fully vaccinated persons continue to face a higher risk of severe disease.

However, the health ministry also informed that the administration may step up the restrictions again to lower the infection rate and protect the unvaccinated.

With vaccination-differentiated measures (VDS) to be fully lifted on Monday, the minister noted that while such restrictions aimed at protecting the ...

It is the best protection for us for whatever may come in December," Ong said. Do it to protect yourself and don't listen too much to the rumours circulating outside," Ong was quoted as saying by The even fewer have adverse reactions after taking boosters compared to taking primary series)," he said. If it's something dangerous, we don't want to be caught off guard," the minister said. In the post, Ong clarified that while being infected with Covid-19 is considered a shot for the purposes of achieving minimum protection, it is not considered as a substitute for a shot to keep up to date with vaccinations. "It's not that VDS doesn't work.

Those eligible can walk into nine vaccination centres to get their jabs. Read more at straitstimes.com.

Preliminary data showed that the Moderna bivalent vaccine is also effective against the Omicron BA.4 and BA.5 variants, and others such as the Delta and Gamma variants, HSA said then. The Moderna bivalent vaccine, which was approved by the Health Sciences Authority (HSA) in September, targets the original Sars-CoV-2 strain of the virus as well as the Omicron BA.1 variant.